Articles | AI for Mobility Medicine
Vol. 35 No. 3 (2025)
Shared diagnostic genes and potential mechanisms between asthma and lung cancer revealed by integrated transcriptomic analysis and machine learning
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 5 May 2025
Accepted: 26 May 2025
Accepted: 26 May 2025
176
Views
144
Downloads
6
HTML
Authors
Lung cancer, a severe malignancy with poor prognosis, poses a formidable public health challenge. Beyond conventional risk factors such as smoking, evidence suggests that chronic respiratory diseases also contribute to its development. Among these, asthma, the second most prevalent chronic respiratory condition, is recognized as a risk factor for lung cancer. Nevertheless, the underlying molecular link between these two diseases remains elusive. Our study, leveraging multi-cohort data integration and employing Weighted Gene Co-expression Network Analysis (WGCNA), identified conserved shared genes between lung cancer and asthma. By constructing the functional landscape of these shared genes, we underscored the pivotal roles of pathways related to lung development and cellular metabolic homeostasis in the pathogenesis of both lung cancer and asthma. Utilizing machine learning-based screening, we identified three hub biomarkers: P2RY14, ANXA3, and SLIT2, which could serve as diagnostic tools for these diseases. In summary, our research provides invaluable insights into the shared mechanisms underlying asthma and lung cancer, and potential diagnostic biomarkers.
Downloads
Download data is not yet available.
Citations
1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209-49. DOI: https://doi.org/10.3322/caac.21660
2. Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature 2018;553:446-54. DOI: https://doi.org/10.1038/nature25183
3. Bade BC, Dela Cruz CS. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med 2020;41:1-24. DOI: https://doi.org/10.1016/j.ccm.2019.10.001
4. GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2020;8:585-96.
5. Huang JY, Jian ZH, Nfor ON, et al. The effects of pulmonary diseases on histologic types of lung cancer in both sexes: a population-based study in Taiwan. BMC Cancer 2015;15:834. DOI: https://doi.org/10.1186/s12885-015-1847-z
6. Huang Q, Huang Y, Xu S, et al. Association of asthma and lung cancer risk: A pool of cohort studies and Mendelian randomization analysis. Medicine (Baltimore) 2024;103:e35060. DOI: https://doi.org/10.1097/MD.0000000000035060
7. Dadgar-Zankbar L, Mokhtaryan M, Bafandeh E, et al. Microbiome and bladder cancer: the role of probiotics in treatment. Future Microbiol 2025;20:73-90. DOI: https://doi.org/10.1080/17460913.2024.2414671
8. Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015;43:e47. DOI: https://doi.org/10.1093/nar/gkv007
9. Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb) 2021;2:100141. DOI: https://doi.org/10.1016/j.xinn.2021.100141
10. Papi A, Brightling C, Pedersen SE, et al. Asthma. Lancet 2018;391:783-800. DOI: https://doi.org/10.1016/S0140-6736(17)33311-1
11. Zhang Q, Cai G, Cui F, et al. The relationship of airflow limitation with lung squamous cell carcinoma: evidence from mendelian randomization analysis. J Cancer Res Clin Oncol 2023;149:6999-7006. DOI: https://doi.org/10.1007/s00432-023-04612-6
12. Engels EA. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther 2008;8:605-15. DOI: https://doi.org/10.1586/14737140.8.4.605
13. Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med 2009;15:303-7. DOI: https://doi.org/10.1097/MCP.0b013e32832c975a
14. Khuri FR, Wu H, Lee JJ, et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res 2001;7:861-7.
15. Hu K, Li K, Lv J, et al. Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma. J Clin Invest 2020;130:1752-66. DOI: https://doi.org/10.1172/JCI124049
16. Stading R, Gastelum G, Chu C, et al. Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer. Semin Cancer Biol 2021;76:3-16. DOI: https://doi.org/10.1016/j.semcancer.2021.07.001
17. Reynaert NL. Glutathione biochemistry in asthma. Biochim Biophys Acta 2011;1810:1045-51. DOI: https://doi.org/10.1016/j.bbagen.2011.01.010
18. Bhosle VK, Tan JM, Li T, et al. SLIT2/ROBO1 signaling suppresses mTORC1 for organelle control and bacterial killing. Life Sci Alliance 2023;6:e202301964. DOI: https://doi.org/10.26508/lsa.202301964
19. Wang J, Ye J, Dang Y, et al. LncRNA PGM5-AS1 inhibits non-small cell lung cancer progression by targeting miRNA-423-5p/SLIT2 axis. Cancer Cell Int 2024;24:216. DOI: https://doi.org/10.1186/s12935-024-03402-5
20. Pilling D, Zheng Z, Vakil V, et al. Fibroblasts secrete Slit2 to inhibit fibrocyte differentiation and fibrosis. Proc Natl Acad Sci U S A 2014;111:18291-6. DOI: https://doi.org/10.1073/pnas.1417426112
Supporting Agencies
This work was supported by Special Scientific Research Project on Wounds/Chronic Diseases (Tigecycline) of Sichuan Medical Association (No. 2024TG53), Science and Technology Plan Project of Ziyang (No. zykjjsc20-yyjc-2023-09)How to Cite
Shared diagnostic genes and potential mechanisms between asthma and lung cancer revealed by integrated transcriptomic analysis and machine learning. (2025). European Journal of Translational Myology, 35(3). https://doi.org/10.4081/ejtm.2025.13952
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.